Jump to navigation
NDRI is leading a clinical trial to establish whether a new medication can help people reduce their ice use.
The National Centre for Clinical Research on Emerging Drugs (NCCRED) has been established to support the provision of clinical treatment interventions to people experiencing problems related to the
Over the past three years, NCETA has partnered with the Queen Elizabeth Hospital’s Clinical Education Centre to conduct a one-day workshop for medical, nursing and allied health staff on identifyin
Many prescribers in Australia have patients experiencing difficulties with their use of pharmaceutical opioids.
NCETA was invited by Business SA to participate in the launch, on Friday 27 July, 2018, of their Ice at Work white paper dealing with methamphetamine and other drug use in the workplace.
Register for NDRI’s 2018 Annual Symposium, this year taking place in Melbourne on Thursday 22 November.
The winner of the National Competition for Excellence in Hepatitis C Health Promotion was announced by CSRH and NDRI on World Hepatitis Day 2018.
NDRI researchers have recently presented two free webinars that are now available online.
This study is part of the POINT (Pain and Opioids in Treatment) study being conducted by the National Drug and Alcohol Research Centre at UNSW Sydney.
Aboriginal and Torres Strait Islander students from Western Sydney and Tasmania will have their stories included in a culturally inclusive school-based drug and alcohol prevention program.
Results of a four-year study of over 1,500 Australians prescribed opioids for chronic non-cancer pain, suggest there is a need for caution in the use of medicinal cannabis for chronic pain.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Thursday 16 August 2018